Discovery one step closer to treatment for Duchenne muscular dystrophy

July 30, 2013 by Raquel Maurier

(Medical Xpress)—A University of Alberta researcher has pinpointed a mutation that brings the medical community another step closer to treating those who suffer from a fatal type of muscular dystrophy. 

Toshifumi Yokota, a muscular dystrophy researcher in the Department of Medical Genetics, led a team of researchers that discovered a mutation that results in dramatic regrowth of the dystrophin, which is a protein that essentially acts like a support beam to keep muscles strong.

Yokota found that lab models with the mutation possessed many unique muscle fibres that are somehow involved with the regrowth of the important protein that is virtually non-existent in those suffering from Duchenne muscular dystrophy. This disorder is an incurable and fatal neuromuscular condition that causes muscles responsible for movement to weaken, which leads to difficulty walking or breathing.

"If we can find the mechanism that causes the dystrophin protein to regrow, it would be a for the treatment of Duchenne muscular dystrophy," said Yokota, who holds Muscular Dystrophy Canada's Friends of Garrett Cumming Research Chair and the H.M. Toupin Neurological Science Chair. "Our discovery is very promising."

Yokota noted the increased didn't result in and the team is continuing their research to find out why. "We are now working on the next steps: what causes these to increase in number?"

The first co-author on the study, published in the peer-reviewed journal PLOS ONE, was Yokota's undergraduate summer student, Merryl Rodrigues.

Garrett Cumming, for whom Yokota's Muscular Dystrophy Canada chair is named, added, "This is very exciting news and hopefully these findings will lead to a viable treatment and ultimately a cure."

Explore further: New breakthrough could help treat muscular dystrophy

Related Stories

New breakthrough could help treat muscular dystrophy

August 13, 2012

A researcher in the Faculty of Medicine & Dentistry at the University of Alberta improved Duchenne muscular dystrophy symptoms in non-human lab models, using a new drug cocktail. The drug combination targets the “hot ...

Preclinical muscular dystrophy data shows promise

November 8, 2012

Cedars-Sinai Heart Institute researchers have found that an experimental compound may help stem the debilitating effects of muscular dystrophy by restoring normal blood flow to muscles affected by the genetic disorder.

Protein injection points to muscular dystrophy treatment

November 27, 2012

Scientists have discovered that injecting a novel human protein into muscle affected by Duchenne muscular dystrophy significantly increases its size and strength, findings that could lead to a therapy akin to the use of insulin ...

Recommended for you

Damaged nerve cells communicate with stem cells

October 7, 2015

Nerve cells damaged in diseases such as multiple sclerosis (MS), 'talk' to stem cells in the same way that they communicate with other nerve cells, calling out for 'first aid', according to new research from the University ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.